Table 4.
Phenotype | Study | Year | β | SE | p value | No. of controls | No. of cases | Unit |
---|---|---|---|---|---|---|---|---|
Type 2 diabetesa | Morris et al (2012) [22] | 2012 | −0.033 | 0.012 | 8.1 × 10−3 | 114,981 | 34,840 | log(OR) |
Fasting glucosea | Dupuis et al (2010) [36] | 2010 | −0.004 | 0.002 | 0.07 | 133,010 | 0 | mmol/l |
Log(fasting insulin)a | Dupuis et al (2010) [36] | 2010 | −0.002 | 0.003 | 0.41 | 108,557 | 0 | pmol/l |
2 h fasting glucosea | Dupuis et al (2010) [36] | 2010 | −0.010 | 0.011 | 0.37 | 42,854 | 0 | mmol/l |
LDL-cholesterola | Global Lipids Genetics Consortium (2013) [41] | 2013 | 0.034 | 0.004 | 5.0 × 10−17 | 172,996 | 0 | IVNT |
Triacylglycerolsa | Global Lipids Genetics Consortium (2013) [41] | 2013 | 0.018 | 0.003 | 5.4 × 10−7 | 177,766 | 0 | IVNT |
HDL-cholesterola | Global Lipids Genetics Consortium (2013) [41] | 2013 | 0.004 | 0.004 | 0.22 | 187,069 | 0 | IVNT |
BMI | Locke et al (2015) [42] | 2015 | 0.001 | 0.004 | 0.88 | 235,991 | 0 | INVT |
Waist-to-hip ratio | Shungin et al (2015) [43] | 2015 | 0.006 | 0.004 | 0.19 | 144,548 | 0 | INVT |
Results are extracted from the largest available GWAS datasets
Metabochip proxy rs2326077
IVNT, inverse normal transformed trait